Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,926
Total Claims
$969K
Drug Cost
1,078
Beneficiaries
$899
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-84%
Opioid rate vs peers
1.5% vs 9.2% avg
+25%
Cost per patient vs peers
$899 vs $719 avg
+80%
Brand preference vs peers
12.0% vs 6.7% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.5%
Opioid Rate
146
Opioid Claims
$1,134
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,179 claims · $838K
Generic: 8,658 claims · $126K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 110 | $127K |
| Empagliflozin | 87 | $112K |
| Semaglutide | 53 | $81K |
| Dulaglutide | 40 | $55K |
| Insulin Glargine,hum.Rec.Anlog | 63 | $51K |
| Mirabegron | 36 | $31K |
| Denosumab | 14 | $24K |
| Sitagliptin Phos/Metformin Hcl | 12 | $21K |
| Sitagliptin Phosphate | 14 | $20K |
| Insulin Aspart | 11 | $16K |
| Insulin Degludec | 13 | $14K |
| Insulin Aspart | 22 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 11 | $13K |
| Fluticasone Propion/Salmeterol | 21 | $13K |
| Budesonide/Formoterol Fumarate | 16 | $9,909 |
Prescribing Profile
Patient Profile
77
Avg Age
66%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data